Difficulty: Medium
Average Score: 93%
Practice
Which of the following malignancies is least likely to occur in a 10-month-old infant?
Correct answer
D
Rationale
In this scenario, the correct answer is D) hepatoblastoma, which is least likely to occur in a 10-month-old infant. Hepatoblastoma primarily affects young children, usually under the age of 3, but it is rare in infants under 1 year old. This malignancy typically arises in the liver and is more commonly seen in toddlers and young children.
Option A) neuroblastoma is a cancer that arises in immature nerve cells and is commonly found in infants and young children. Option B) nephroblastoma, also known as Wilms tumor, is a type of kidney cancer that predominantly affects children between the ages of 2 and 5 years old. Option C) retinoblastoma is a malignancy of the eye that often presents in early childhood, typically before the age of 5.
Understanding the epidemiology and age distribution of different malignancies is crucial in pediatric primary care. By knowing the typical age ranges for specific cancers, healthcare providers can better assess and manage young patients presenting with concerning symptoms. This knowledge aids in early detection, appropriate referral to specialists, and timely intervention, ultimately improving outcomes for pediatric oncology patients.
Option A) neuroblastoma is a cancer that arises in immature nerve cells and is commonly found in infants and young children. Option B) nephroblastoma, also known as Wilms tumor, is a type of kidney cancer that predominantly affects children between the ages of 2 and 5 years old. Option C) retinoblastoma is a malignancy of the eye that often presents in early childhood, typically before the age of 5.
Understanding the epidemiology and age distribution of different malignancies is crucial in pediatric primary care. By knowing the typical age ranges for specific cancers, healthcare providers can better assess and manage young patients presenting with concerning symptoms. This knowledge aids in early detection, appropriate referral to specialists, and timely intervention, ultimately improving outcomes for pediatric oncology patients.